Rafeh Naqash: A proof-of-concept study at the intersection of Machine learning and phase 1 trial-to -patient matching!
Rafeh Naqash posted on X about recent paper by him as co-author, titled “Harnessing explainable artificial intelligence for patient-to-clinical-trial matching: A proof-of-concept pilot study using phase I oncology trials” published on Plos One.
Authors: Satanu Ghosh, Hassan Mohammed Abushukair, Arjun Ganesan, Chongle Pan, Abdul Rafeh Naqash, Kun Lu
“Great to see this finally published : A proof-of-concept study at the intersection of Machine learning and phase 1 trial-to -patient matching! Labour of love funded through OU Norman pilot grant.”
Abdul Rafeh Naqash is an Assistant Professor in the early phase division of the Stephenson Cancer Center at the University of Oklahoma. Dr. Naqash focuses on conducting innovative clinical trials and biomarker-based research. Dr. Naqash has published in high-impact journals and has collaborated widely with researchers worldwide.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023